Invokana Lawsuit Plaintiff Claims Drug Caused Patient’s Kidney Failure Development

March 30, 2016 – – TheProductLawyers.com reports on allegations made by a plaintiff in an Invokana lawsuit which claims that the new-generation, type-2 diabetes drug Invokana can cause kidney damage and kidney failure for those taking it. The drug has also been connected to these concerning potential side effects through adverse event reports received by the U.S. Food and Drug Administration. The agency, in fact, reported having received 50 adverse event reports discussing renal impairment and kidney failure among patients using the drug.

Invokana gained FDA approval in March of 2013. The drug was designed to assist patients struggling with type-2 diabetes by helping to maintain their blood sugar (glucose) levels. To do this, the drug prevents the kidneys from reabsorbing excess sugar and instead using them to excrete that excess sugar from the body via urination. Invokana relies heavily on the kidneys to work in this fashion, and, therefore, it is a concern that the drug may place increased stress on these organs.

In December of 2015, the FDA released a public safety warning indicating that they were requiring Invokana manufacturer Janssen Pharmaceuticals (a subdivision of Johnson & Johnson corporation) to alter the product’s warning label to better reflect some new potential side effect concerns involving a condition known as diabetic ketoacidosis and urinary tract infections (UTIs).

The FDA has also noted that they received 19 adverse event reports which detailed patients who had developed these potentially life-threatening health problems that began as urinary tract infections (UTIs) and later, spread into blood and kidney infections. Each of the 19 patients discussed in the adverse event reports were noted to have required hospitalization and dialysis for kidney failure. Because damage sustained to the kidneys is unable to be repaired, patients with seriously damaged kidneys generally require dialysis treatments as they await complete kidney transplants.

The attorneys of Banville Law understand the concern that these potentially linked side effects may cause patients currently dependent upon Invokana or other SGLT2 class inhibitor drugs. At this time, they are working to keep the public well informed of any important information surrounding these drugs. To accomplish this, they sponsor TheProductLawyers.com, an online resource website. In addition, they are currently working to assist patients who have taken Invokana or another SGLT2 inhibitor class drug and who feel that this drug caused them to suffer from health problems. Banville Law attorneys hope to help ensure that affected individuals will be provided the important opportunity to fully investigate their legal rights in the matter. Those affected could qualify for substantial compensation. To help these individuals, Banville Law is currently offering complimentary legal consultations to qualified parties.

To ask questions regarding Invokana lawsuits, or to request additional information, please contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60008981